The U.S. Department of Health and Human Services’ (HHS) Office for Civil Rights has launched an investigation into alleged patient- privacy violations at Walgreens, following complaints that chain’s new pharmacy design is putting sensitive patient information at risk, according to the Wall Street Journal.
Barry Bryant is owner of Barney's Pharmacy in Augusta, Ga. He and his clinical pharmacy educator, Jake Galdo, discuss some of the ways this new technology can be used in the pharmacy.
FDA has approved once-daily topiramate extended-release capsules for initial monotherapy to treat partial-onset or primary generalized tonic-clonic seizures.
Benzodiazepines and opioid medications have dangerous synergistic effects. The use of both has climbed in the last decade, and so has co-prescription.
As pharmaceutical manufacturers and other life sciences companies cut back their budgets, they are looking for technological solutions.
The National Community Pharmacists Association is asking Iowa’s Gov. Terry Branstad to sign into law H.F. 2297 legislation that would provide a level of transparency for how pharmacy benefit managers (PBMs) determine reimbursement for multiple source generic drugs. The legislation would give the insurance commissioner authority to request information from PBMs in Iowa, according to a March 11 letter from NCPA to the governor.
A penicillin "allergy" label adversely affects the quantity and quality of healthcare in hospitalized patients, a new study reports.
The message for U.S. pharmacies and pharmacy chains: Follow the lead of CVS Caremark and halt pharmacy tobacco sales.
While the big chains compete aggressively for preferred provider status, indies and small chains have a tougher time cutting copays and network prices.
NCPA study finds that community pharmacy med-synch programs can improve patients’ medication adherence and boost the pharmacy's bottom line.
Pharmacists cannot solve the drug abuse problem, but they can refrain from abetting drug-seekers - and give chronic-pain patients the support they deserve.
In the wake of the recent Rite Aid HIV settlement, pharmacists face a new Catch 22.
Don't let the prescriber's hostility stop you from doing the right thing. As the pharmacist, you're the Rx expert.
How much do you identify with your work? Does your role as a pharmacist determine your sense of self? Be careful what you tell yourself. Maybe think again.
Unsalable quantities of expensive branded medications and specialty drugs. Skyrocketing prices for generic drugs. Medicaid rules about what to dispense. And there's more.
CMS is proposing a modified interpretation of the existing non-interference provisions that would remove any limitation on CMS’ regulation of the relationship between pharmacies and plan sponsors.
What would you do if you scrambled through that 3.5 hour window, only to find a colleague waiting with his foot stuck out?
Approved in October 2013 for two patient groups, Riociguat (Adempas, Bayer) is a first-in-class sGC stimulator.
Compared to plasma, treatment with 4-factor PCC for warfarin reversal in patients with intracerebral hemorrhage does not seem to reduce 30-day all-cause mortality.
In the pharmacy, an array of foot-care products awaits patients who can't stand it anymore.
Pharmacists who collaborate with ACOs can find many ways to exercise their skills and expand their knowledge. Partnerships are popping up everywhere, and so are the opportunities.
ISMP reports that a growing number of cases of oral vaccines intended to protect children against rotavirus gastroenteritis are mistakenly being injected.
Myelita Melton is CEO of SpeakEasy Communications. With the ever-increasing Spanish-speaking population in the United States, Melton says either your pharmacy will find a way to better accommodate this group or your competitors will.
In 2013, physician assistants, nurse practitioners, and others wrote nearly a third of the painkiller prescriptions issued, according to an investigation by the Milwaukee Journal Sentinel and Medpage Today.
Pharmacy groups, representing more than 100,000 pharmacists in different pharmacy practice settings, have written to CMS Administrator Marilyn B. Tavenner to express their support for the expansion of medication therapy management (MTM) services to Medicare Part D beneficiaries in the CMS proposal released in early January.
